Ondansetron Orally Disintegrating Tablets

SOL #: SPE2D2-25-R-0018Solicitation

Overview

Buyer

DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Aug 7, 2025
2
Last Updated
Feb 23, 2026
3
Submission Deadline
Feb 23, 2026, 8:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Logistics Agency (DLA) Troop Support is soliciting proposals for Ondansetron Orally Disintegrating Tablets (ODT) to establish a national supply source for the Department of Defense (DoD), Department of Veterans Affairs (VA), Indian Health Service (IHS), and Bureau of Prisons (BoP) via its Pharmaceutical Prime Vendor (PPV) program. This is an Unrestricted acquisition for a firm-fixed-price requirements contract. Proposals are due February 23, 2026.

Scope of Work

The requirement includes Ondansetron ODT in 4 MG (30 count) and 8 MG (10 and 30 count) bottles. Key requirements involve specific packaging standards (unit of use, child-proof closures, minimum bottle volume and circumference, label dimensions, GS1-128 or HIBCC barcode labeling). Offerors must have FDA approval (NDA, ANDA, or Biologic License) by the closing date and manufacturing facilities with acceptable cGMP status. Product information must be registered with RXNorm, First Data Bank, and Medi-Span prior to contract performance.

Contract Details

  • Type: Firm-fixed-price requirements contract.
  • Period of Performance: One base year with four option years, for a maximum term of five years.
  • Set-Aside: Unrestricted.
  • NAICS Code: 325412 (Drugs And Biologicals), Size Standard: 1300 employees.
  • Contract Performance Date: 45 calendar days after award.
  • Contract Price Effective Date: No more than 60 calendar days after award.

Submission & Evaluation

Offers must be submitted electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS). The proposal due date is February 23, 2026, at 3:00 PM EST. Evaluation will be based on Lowest Price Technically Acceptable (LPTA) criteria, with award made to the responsible offeror providing a technically acceptable proposal and the lowest evaluated aggregate price. Proposals must include a Non-Price Proposal (Volume 1) and a Price Proposal (Volume 2). Offerors are required to complete representations and certifications electronically via SAM.gov.

Additional Notes

A reverse auction may be utilized for price discussions. Successful offerors must enter into business-to-business agreements with DLA and VA PPV contractors. The contract price may be adjusted by distribution fees.

People

Points of Contact

Jason C. WraySECONDARY

Files

Files

No files attached to this opportunity

Versions

Version 4
Solicitation
Posted: Feb 23, 2026
View
Version 3
Solicitation
Posted: Jan 29, 2026
View
Version 2Viewing
Solicitation
Posted: Jan 22, 2026
Version 1
Pre-Solicitation
Posted: Aug 7, 2025
View